Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when XERS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsXeris Biopharma reports Q1 2026 earnings and business highlights
Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read
Key Changes
-
medium
Xeris issued its first quarter 2026 financial results and operational updates through a press release on May 7, 2026. The actual financial figures and business metrics are contained in the attached exhibit rather than the 8-K body.
Item 2.02 verify on EDGAR →
Summary
Xeris Biopharma filed a routine quarterly earnings announcement for the three months ended March 31, 2026. This is a standard disclosure practice where companies report their financial performance and operational highlights to shareholders and the market. The 8-K itself serves as a notification mechanism, with the detailed financial results provided in the attached press release exhibit.
For retail investors, this represents a regular checkpoint to assess the company's financial health and business progress. The medium materiality reflects that while quarterly earnings are important for tracking company performance, this filing is procedural in nature. Investors should review the attached press release for specific revenue figures, earnings metrics, and management commentary on business developments during the quarter to understand how Xeris is executing against its strategic goals.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 7, 2026, Xeris Biopharma Holdings, Inc. (the “Company”) issued a press release containing information about the Company’s results of operations and business highlights for the three months ended March 31, 2026.
The company disclosed its first quarter 2026 financial results and operational updates through a press release. The 8-K itself does not contain the actual financial figures or business highlights, which are provided in the attached press release exhibit. This is a standard quarterly earnings announcement filing.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify